Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0133 | 0.451 | 1 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0055 | 0.137 | 0.3038 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.004 | 0.0782 | 0.1733 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.004 | 0.0782 | 0.1733 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.027 | 1 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0133 | 0.451 | 1 |
Brugia malayi | Hydroxymethylglutaryl-coenzyme A reductase family protein | 0.0133 | 0.451 | 0.451 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0133 | 0.451 | 1 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0055 | 0.137 | 0.3038 |
Echinococcus multilocularis | protein dispatched 1 | 0.0055 | 0.137 | 0.3038 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0055 | 0.137 | 0.3038 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.004 | 0.0782 | 0.1733 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0133 | 0.451 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.451 | 0.451 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.004 | 0.0782 | 0.1733 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.004 | 0.0782 | 0.5 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.004 | 0.0782 | 0.1733 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0062 | 0.1677 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0133 | 0.451 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0782 | 0.0782 |
Schistosoma mansoni | patched 1 | 0.0055 | 0.137 | 0.3038 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.004 | 0.0782 | 0.1733 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0055 | 0.137 | 0.3038 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0055 | 0.137 | 0.137 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0062 | 0.1677 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0062 | 0.1677 | 1 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0055 | 0.137 | 0.3038 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.0133 | 0.451 | 0.5 |
Echinococcus multilocularis | protein patched | 0.0055 | 0.137 | 0.3038 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0021 | 0 | 0.5 |
Brugia malayi | CHE-14 protein | 0.0055 | 0.137 | 0.137 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0062 | 0.1677 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.137 | 0.6576 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.004 | 0.0782 | 0.1733 |
Onchocerca volvulus | 0.0021 | 0 | 0.5 | |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0133 | 0.451 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.137 | 0.137 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.004 | 0.0782 | 0.1733 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0055 | 0.137 | 0.3038 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0133 | 0.451 | 1 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.004 | 0.0782 | 0.0782 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.